.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Chubb
Deloitte
Merck
Accenture
Cipla
US Army
Chinese Patent Office
Argus Health
Mallinckrodt

Generated: June 27, 2017

DrugPatentWatch Database Preview

ROSIGLITAZONE MALEATE Drug Profile

« Back to Dashboard

Which patents cover Rosiglitazone Maleate, and when can generic versions of Rosiglitazone Maleate launch?

Rosiglitazone Maleate is a drug marketed by Teva and Teva Pharms Usa and is included in three NDAs.

The generic ingredient in ROSIGLITAZONE MALEATE is metformin hydrochloride; rosiglitazone maleate. There are forty-seven drug master file entries for this compound. One supplier is listed for this compound. There are six tentative approvals for this compound. Additional details are available on the metformin hydrochloride; rosiglitazone maleate profile page.

Summary for Tradename: ROSIGLITAZONE MALEATE

Patents:0
Applicants:2
NDAs:3
Bulk Api Vendors: see list38
Clinical Trials: see list388
Patent Applications: see list2,394
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ROSIGLITAZONE MALEATE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva
ROSIGLITAZONE MALEATE
rosiglitazone maleate
TABLET;ORAL076747-001Jan 25, 2013ABRXNoNo► Subscribe► Subscribe
Teva Pharms Usa
ROSIGLITAZONE MALEATE AND GLIMEPIRIDE
glimepiride; rosiglitazone maleate
TABLET;ORAL078709-003Apr 1, 2016RXNoNo► Subscribe► Subscribe
Teva Pharms Usa
ROSIGLITAZONE MALEATE AND GLIMEPIRIDE
glimepiride; rosiglitazone maleate
TABLET;ORAL078709-001Apr 1, 2016RXNoYes► Subscribe► Subscribe
Teva
ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE
metformin hydrochloride; rosiglitazone maleate
TABLET;ORAL077337-005May 19, 2017RXNoNo► Subscribe► Subscribe
Teva Pharms Usa
ROSIGLITAZONE MALEATE AND GLIMEPIRIDE
glimepiride; rosiglitazone maleate
TABLET;ORAL078709-005Apr 1, 2016RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Covington
Novartis
QuintilesIMS
AstraZeneca
Harvard Business School
Julphar
US Department of Justice
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot